000			01963 a2200577 4500
005			20250513050230.0
264		0	_c19950403
008			199504s 0 0 eng d
022			_a8756-3282
024	7		_a10.1016/8756-3282(94)90322-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aNishida, S
245	0	0	_aIncreased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. _h[electronic resource]
260			_bBone _c
300			_a717-23 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlkaline Phosphatase _xmetabolism
650	0	4	_aAnimals
650	0	4	_aBiomechanical Phenomena
650	0	4	_aBone Density _xdrug effects
650	0	4	_aBone Development _xdrug effects
650	0	4	_aBone Marrow _xdrug effects
650	0	4	_aBone Marrow Cells
650	0	4	_aCell Count
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aColony-Forming Units Assay
650	0	4	_aFemale
650	0	4	_aFemur _xdrug effects
650	0	4	_aHumans
650	0	4	_aInjections, Subcutaneous
650	0	4	_aOsteoclasts _xdrug effects
650	0	4	_aParathyroid Hormone _xadministration & dosage
650	0	4	_aPeptide Fragments _xadministration & dosage
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aStem Cells _xcytology
650	0	4	_aTeriparatide
650	0	4	_aTibia _xdrug effects
700	1		_aYamaguchi, A
700	1		_aTanizawa, T
700	1		_aEndo, N
700	1		_aMashiba, T
700	1		_aUchiyama, Y
700	1		_aSuda, T
700	1		_aYoshiki, S
700	1		_aTakahashi, H E
773	0		_tBone _gvol. 15 _gno. 6 _gp. 717-23
856	4	0	_uhttps://doi.org/10.1016/8756-3282(94)90322-0 _zAvailable from publisher's website
999			_c7872642 _d7872642